Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus sufentanil for anesthesia in hysteroscopic surgery
ChiCTR2300076050Phase 4Not yet recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Sep 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, sufentanil and propofol in hysteroscopic surgery (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoint: Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
esketaminesufentanilpropofol
03
Conditions
hysteroscopic surgery
Beyond the preview
Go deeper on ChiCTR2300076050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076050.